CSF NfL seems to be a relatively weak predictor of conversion to CDMS from both radiologically isolated syndrome (RIS) and CIS [37, 38], and we could previously confirm that CSF NfL levels are moderate predictors of EDA-3 status within 24 months in patients with early RRMS [39]. This evidence concerns the gene NEFL and in situ carcinoma.